Serteyn, D.; Graide, H.; Ceusters, J.; Vandersmissen, M.; Salciccia, A.; Sandersen, C.; Lejeune, J.-P.
Clinical Outcomes Following Intra-Articular Administration of Autologous Muscle-Derived Mesenchymal Stem Cells in Horses with Chronic Osteoarthritis: A Prospective Open-Label Study. Animals 2026, 16, 1523.
https://doi.org/10.3390/ani16101523
AMA Style
Serteyn D, Graide H, Ceusters J, Vandersmissen M, Salciccia A, Sandersen C, Lejeune J-P.
Clinical Outcomes Following Intra-Articular Administration of Autologous Muscle-Derived Mesenchymal Stem Cells in Horses with Chronic Osteoarthritis: A Prospective Open-Label Study. Animals. 2026; 16(10):1523.
https://doi.org/10.3390/ani16101523
Chicago/Turabian Style
Serteyn, Didier, Hélène Graide, Justine Ceusters, Maxime Vandersmissen, Alexandra Salciccia, Charlotte Sandersen, and Jean-Philippe Lejeune.
2026. "Clinical Outcomes Following Intra-Articular Administration of Autologous Muscle-Derived Mesenchymal Stem Cells in Horses with Chronic Osteoarthritis: A Prospective Open-Label Study" Animals 16, no. 10: 1523.
https://doi.org/10.3390/ani16101523
APA Style
Serteyn, D., Graide, H., Ceusters, J., Vandersmissen, M., Salciccia, A., Sandersen, C., & Lejeune, J.-P.
(2026). Clinical Outcomes Following Intra-Articular Administration of Autologous Muscle-Derived Mesenchymal Stem Cells in Horses with Chronic Osteoarthritis: A Prospective Open-Label Study. Animals, 16(10), 1523.
https://doi.org/10.3390/ani16101523